AAAAAA

   
Results: 1-3 |
Results: 3
Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S-typhivaccines; effect of formulation on safety and immunogenicity
Authors: Dilts, DA Riesenfeld-Orn, I Fulginiti, JP Ekwall, E Granert, C Nonenmacher, J Brey, RN Cryz, SJ Karlsson, K Bergman, K Thompson, T Hu, B Bruckner, AH Lindberg, AA
Citation: Da. Dilts et al., Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S-typhivaccines; effect of formulation on safety and immunogenicity, VACCINE, 18(15), 2000, pp. 1473-1484
Polyosides (encapsulated bacteria)
Authors: Lindberg, AA
Citation: Aa. Lindberg, Polyosides (encapsulated bacteria), CR AC S III, 322(11), 1999, pp. 925-932
Glycoprotein conjugate vaccines
Authors: Lindberg, AA
Citation: Aa. Lindberg, Glycoprotein conjugate vaccines, VACCINE, 17, 1999, pp. S28-S36
Risultati: 1-3 |